Inhibition of DNA polymerase eta‐mediated translesion DNA synthesis with small molecule sensitises ovarian cancer stem‐like cells to chemotherapy
British Journal of Pharmacology · 2025
DOI: 10.1111/bph.70037 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, 2025. Verfasst von Subhankar Bose und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biology and Inflammatory Disorder Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India. Hauptthemen laut MEDLINE: Ovarian Neoplasms, DNA-Directed DNA Polymerase, Neoplastic Stem Cells, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India, CSIR - Indian Institute of Chemical Biology.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background and Purpose Chemoresistance and tumour relapse pose significant challenges in achieving successful chemotherapy outcomes. Targeting DNA polymerase eta (Pol ƞ)‐mediated mutagenic translesion DNA synthesis (TLS) has emerged as a promising strategy for improving chemotherapy. However, the identification of small molecule inhibitors targeting Pol ƞ ‐ mediated TLS with high in vivo efficacy remains a challenge. Experimental Approach The small molecule was identified through in silico screening. Pol η inhibitory potential of the identified small molecule was validated by a fluorescent‐based reporter strand displacement assay. Flow cytometry was conducted to analyse the CD44 + CD117 + cancer stem‐like cell (CSC) population and live‐dead cell population. Xenograft mouse models were used to test the CSC sensitising potential. Key Results We screened and identified chrysin as a small‐molecule inhibitor that sensitises ovarian cancer stem‐like cells to cisplatin treatment by inhibiting Pol ƞ ‐mediated TLS. Chrysin effectively inhibits Pol ƞ expression, mitigates cancer stem‐like cell enrichment and enhances cisplatin‐induced cell death both in vitro and in vivo . Furthermore, chrysin treatment reduces spontaneous and cisplatin‐induced mutagenesis. Pre‐treatment with chrysin attenuates cisplatin‐induced haematological toxicity and suppresses tumour growth in human ovarian cancer xenografts. Conclusions and Implications These results establish chrysin as a novel class of TLS inhibitors and highlight its potential as a chemotherapy adjuvant for overcoming chemoresistance and improving treatment outcomes in ovarian cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Biology and Inflammatory Disorder Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
- Department of Biochemistry, Central Ayurveda Research Institute, Kolkata, India.
- Organic and Medicinal Chemistry Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India.
- Department of Chemical Science, Indian Institute of Science Education and Research Berhampur, Odisha, India.
- Cell Biology and Physiology Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India.
Förderung
- Council of Scientific and Industrial Research, India
- CSIR - Indian Institute of Chemical Biology
Zitieren
APA
Bose, S., Saha, P., Alam, M. T., Chatterjee, B., Sarkar, M., Dixit, A. K., Kumar, D., Pathak, R. K., Tripathi, P. P., & Srivastava, A. K. (2025). Inhibition of DNA polymerase eta‐mediated translesion DNA synthesis with small molecule sensitises ovarian cancer stem‐like cells to chemotherapy. British Journal of Pharmacology. https://doi.org/10.1111/bph.70037
Vancouver
Bose S, Saha P, Alam MT, Chatterjee B, Sarkar M, Dixit AK, et al. Inhibition of DNA polymerase eta‐mediated translesion DNA synthesis with small molecule sensitises ovarian cancer stem‐like cells to chemotherapy. British Journal of Pharmacology. 2025. doi:10.1111/bph.70037
BibTeX
@article{Bose2025,
author = {Bose, Subhankar and Saha, Priyanka and Alam, Md Tanjim and Chatterjee, Bilash and Sarkar, Mrinmoy and Dixit, Amit Kumar and Kumar, Deepak and Pathak, Rakesh Kumar and Tripathi, Prem Prakash and Srivastava, Amit Kumar},
title = {Inhibition of DNA polymerase eta‐mediated translesion DNA synthesis with small molecule sensitises ovarian cancer stem‐like cells to chemotherapy},
journal = {British Journal of Pharmacology},
year = {2025},
doi = {10.1111/bph.70037}
}
EUVIMED